Literature DB >> 18842173

Evaluation of plasma antioxidant levels during different phases of illness in adult patients with bipolar disorder.

D De Berardis1, C M Conti, D Campanella, A Carano, B Di Giuseppe, A Valchera, L Tancredi, N Serroni, A M Pizzorno, M Fulcheri, F Gambi, G Sepede, F S Moschetta, R M Salerno, F M Ferro.   

Abstract

The aim of the present study is to evaluate role of plasma antioxidants (albumin, bilirubin and uric acid) in patients suffering from type I Bipolar Disorder (BD-I) during different phases of illness: acute mania, euthymia and bipolar depression. Medical records of consecutive 110 BD-I patients (38 patients with acute mania, 35 in euthymic state, full remission, and 37 in depressive phase) were reviewed to evaluate plasma antioxidant levels. Laboratory data of 40 healthy controls were also obtained. The scores of Young Mania Rating Scale (YMRS), Bech-Rafaelsen Manic Rating Scale (BRMRS) and Hamilton Rating Scale for Depression (HAM-D) were evaluated. Serum uric acid levels were higher in acute mania than other patient subgroups and healthy controls. Serum uric acid levels directly correlated with BRMRS and YMRS scores. No differences were found between clinical groups during different phases and healthy controls concerning albumin and bilirubin. In conclusion, the results of the present study support the notion that serum uric acid levels may be higher in patients with BP-I (especially during manic phases) which may suggest a dysregulation of the purinergic system. However, limitations should be considered and further studies are needed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18842173

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  9 in total

1.  Increased uric acid levels in drug-naïve subjects with bipolar disorder during a first manic episode.

Authors:  Giacomo Salvadore; Carlos I Viale; David A Luckenbaugh; Vanessa C Zanatto; Luiz V Portela; Diogo O Souza; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-03-03       Impact factor: 5.067

Review 2.  Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.

Authors:  Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  Depress Anxiety       Date:  2011-02-24       Impact factor: 6.505

Review 3.  Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.

Authors:  Robin Ortiz; Henning Ulrich; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-11-07       Impact factor: 5.067

Review 4.  Purinergic signaling and energy homeostasis in psychiatric disorders.

Authors:  D Lindberg; D Shan; J Ayers-Ringler; A Oliveros; J Benitez; M Prieto; R McCullumsmith; D-S Choi
Journal:  Curr Mol Med       Date:  2015       Impact factor: 2.222

5.  Quantitative detection of methylated SOCS-1 in schizophrenia and bipolar disorder considering SOCS-1 -1478CA/del polymorphism and clinical parameters.

Authors:  Hasan Mervan Aytac; Sacide Pehlivan; Mustafa Pehlivan; Yasemin Oyaci
Journal:  Ir J Med Sci       Date:  2022-05-20       Impact factor: 1.568

6.  Early Diagnosis of Bipolar Disorder Coming Soon: Application of an Oxidative Stress Injury Biomarker (BIOS) Model.

Authors:  Zhiang Niu; Xiaohui Wu; Yuncheng Zhu; Lu Yang; Yifan Shi; Yun Wang; Hong Qiu; Wenjie Gu; Yina Wu; Xiangyun Long; Zheng Lu; Shaohua Hu; Zhijian Yao; Haichen Yang; Tiebang Liu; Yong Xia; Zhiyu Chen; Jun Chen; Yiru Fang
Journal:  Neurosci Bull       Date:  2022-05-19       Impact factor: 5.271

7.  Patients With Drug-Naive Bipolar Disorder in Remission After 8 Weeks of Treatment Had Decreased Serum Uric Acid Concentrations.

Authors:  Jing-Xu Chen; Li-Gang Zhang; Ke-Zhi Liu; Hong-Mei Chen; Shuang-Jiang Zhou; Ning Wang; Yun-Long Tan; Shao-Li Wang; Alison Jones; Fu-De Yang; Xu-Feng Huang
Journal:  Front Psychiatry       Date:  2019-10-31       Impact factor: 4.157

8.  The prevalence and associated clinical correlates of hyperuricemia in patients with bipolar disorder.

Authors:  Shuyun Li; Xiaobing Lu; Xiaodong Chen; Zebin Huang; Hui Zhou; Zezhi Li; Yuping Ning
Journal:  Front Neurosci       Date:  2022-09-16       Impact factor: 5.152

9.  Individuals with bipolar disorder have a higher level of uric acid than major depressive disorder: a case-control study.

Authors:  Zhe Lu; Yingtan Wang; Guanglei Xun
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.